IVBIY - Innovent Biologics reports interim results
2025-08-27 06:27:08 ET
More on Innovent Biologics
- Neutral On Innovent Biologics: Hard To Justify Its Premium
- How mazdutide compares against weight loss therapies from Novo Nordisk, Lilly
- Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent gains approval for mazdutide
- Historical earnings data for Innovent Biologics
- Financial information for Innovent Biologics